(S (NP (NNP HIV) (HYPH -) (NNP 1)) (VP (MD can) (VP (VB disseminate) (PP (IN between) (NP (ADJP (JJ susceptible)) (NNS cells))) (PP (PP (IN by) (NP (NP (CD two) (NNS mechanisms)) (: :) (NP (NP (ADJP (NN cell) (HYPH -) (JJ free)) (NN infection)) (PP (VBG following) (NP (NP (NML (NN fluid) (HYPH -) (NN phase)) (NN diffusion)) (PP (IN of) (NP (NNS virions)))))))) (CC and) (PP (IN by) (NP (NP (ADJP (RB highly) (HYPH -) (JJ efficient)) (NML (NML (JJ direct) (NN cell)) (HYPH -) (PP (IN to) (HYPH -) (NP (NN cell)))) (NN transmission)) (PP (IN at) (NP (NML (JJ immune) (NN cell)) (NNS contacts)))))))) (. .))
(S (NP (NP (DT The) (NN contribution)) (PP (IN of) (NP (NP (DT this) (NN hybrid) (VBG spreading) (NN mechanism)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN characteristic)) (PP (IN of) (NP (DT some) (JJ important) (NN computer) (NN worm) (NNS outbreaks)))) (, ,) (PP (IN to) (NP (NP (NML (NNP HIV) (HYPH -) (NNP 1)) (NN progression)) (ADVP (FW in) (FW vivo)))))))))) (VP (VBZ remains) (ADJP (JJ unknown))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP present) (NP (NP (DT a) (JJ new) (JJ mathematical) (NN model)) (SBAR (WHNP (WDT that)) (S (ADVP (RB explicitly)) (VP (VBZ incorporates) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NNP HIV) (HYPH -) (CD 1)))) (S (VP (TO to) (VP (VP (VB use) (NP (NN hybrid)) (S (VP (VBG spreading) (NP (NNS mechanisms))))) (CC and) (VP (VB evaluate) (NP (NP (DT the) (NNS consequences)) (PP (IN for) (NP (NML (NNP HIV) (HYPH -) (NNP 1)) (NN pathogenenesis))))))))))))) (. .))
(S (NP (DT The) (NN model)) (VP (VP (VBZ captures) (NP (NP (DT the) (JJ major) (NNS phases)) (PP (IN of) (NP (NP (DT the) (NML (NNP HIV) (HYPH -) (CD 1)) (NN infection) (NN course)) (PP (IN of) (NP (NP (DT a) (NN cohort)) (PP (IN of) (NP (ADJP (NN treatment) (JJ naive)) (NNS patients))))))))) (CC and) (VP (ADVP (RB also)) (ADVP (RB accurately)) (VBZ predicts) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (NP (DT the) (NML (JJ Short) (NN Pulse)) (JJ Anti-Retroviral) (NN Therapy)) (PP (IN at) (NP (NML (NNP Seroconversion) (-LRB- -LRB-) (NNP SPARTAC) (-RRB- -RRB-)) (NN trial)))))))) (. .))
(S (S (VP (VBG Using) (NP (NP (DT this) (NN model)) (SBAR (S (NP (PRP we)) (VP (VP (VBP find) (SBAR (SBAR (IN that) (S (NP (NP (NN hybrid)) (VP (VBG spreading))) (VP (VP (VBZ is) (ADJP (JJ critical) (PP (IN to) (NP (NN seed))))) (CC and) (VP (VB establish) (NP (NN infection)))))) (, ,) (CC and) (SBAR (IN that) (FRAG (NP (NML (NN cell) (HYPH -) (IN to) (HYPH -) (NN cell)) (NN spread)))))) (CC and) (VP (VBD increased) (NP (NML (NN CD4) (SYM +) (NN T)) (NN cell) (NN activation))))))))) (VP (VBP are) (ADJP (JJ important) (PP (IN for) (NP (NML (NNP HIV) (HYPH -) (NNP 1)) (NN progression))))) (. .))
(S (ADVP (RB Notably)) (, ,) (NP (DT the) (NN model)) (VP (VBZ predicts) (SBAR (IN that) (S (NP (NML (NN cell) (HYPH -) (IN to) (HYPH -) (NN cell)) (NN spread)) (VP (VBZ becomes) (ADJP (RB increasingly) (JJ effective)) (SBAR (IN as) (S (NP (NN infection)) (VP (VP (VBZ progresses)) (CC and) (ADVP (RB thus)) (VP (MD may) (VP (VB present) (NP (DT a) (JJ considerable) (NN treatment) (NN barrier))))))))))) (. .))
(S (NP (NP (VBG Deriving) (NNS predictions)) (PP (IN of) (NP (NP (NP (JJ various) (NNS treatments) (POS ')) (NN influence)) (PP (IN on) (NP (NML (NNP HIV) (HYPH -) (NNP 1)) (NN progression)))))) (VP (VP (VBZ highlights) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (JJR earlier) (NN intervention))))) (CC and) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NNS treatments)) (VP (ADVP (RB effectively)) (VBG targeting) (NP (NP (NML (NN cell) (HYPH -) (IN to) (HYPH -) (NN cell)) (NN HIV) (HYPH -) (CD 1)) (NP (NN spread))))) (VP (MD can) (VP (VB delay) (NP (NN progression)) (PP (IN to) (NP (NNP AIDS))))))))) (. .))
(S (NP (DT This) (NN study)) (VP (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NN hybrid)) (VP (VBG spreading))) (VP (VBZ is) (NP (NP (DT a) (JJ fundamental) (NN feature)) (PP (IN of) (NP (NNP HIV) (NN infection)))))))) (, ,) (CC and) (VP (VBZ provides) (NP (DT the) (JJ mathematical) (NN framework)) (S (VP (VBG incorporating) (NP (DT this) (NN feature)) (PP (IN with) (SBAR (WHNP (WDT which)) (S (VP (TO to) (VP (VB evaluate) (NP (JJ future) (JJ therapeutic) (NNS strategies))))))))))) (. .))
